In light of the coronavirus pandemic, the Drug Enforcement Administration (DEA) has partnered with SAMHSA to ensure authorized practitioners may admit and treat new patients with opioid use disorder (OUD) during the public health emergency.
In response to the Novel Coronavirus Disease (COVID-19) pandemic, SAMHSA is providing updates to Frequently Asked Questions regarding the provision of methadone and buprenorphine for the treatment of Opioid Use Disorder for new and existing patients.
Tips for Community-based Syringe Services and Harm Reduction Providers DOWNLOAD THIS DOCUMENT
Harm Reduction during the COVID-19 Outbreak DOWNLOAD THIS DOCUMENT
This is an important update regarding GPRA interview procedures in light of the COVID-19 pandemic. As long as Governor Whitmer’s restrictions are in place regarding the limiting of public gatherings, the intake, 6-month follow-up, and discharge GPRA interviews may be conducted over the phone.
This document explains the process of a GPRA Administrative Discharge for the SOR grant.
This flow chart with help SOR funded peer recovery coaches determine if they need to conduct an intake GPRA.